SPECIAL SEMINAR SPONSORED by
the School of Arts and Sciences, the Leonard Davis Institute of Health Economics, and the Robert Wood Johnson Health and Society Scholars Program

P. ROY VAGELOS
Retired Chairman of the Board and Chief Executive Officer
Merck & Co., Inc, and a
uthor of Medicine, Science, and Merck

The Past and Future of the Pharmaceutical/Biotech Industry

Tuesday, April 20, 2004
3:00 - 4:30 PM
245 Huntsman Hall

(Reception and book signing to follow in Huntsman MBA Lounge)

Abstract Summary of talk

Biosketch:
Dr. Vagelos is Emeritus Trustee of the University of Pennsylvania having served as a trustee since 1988. He was Chairman of the Board of the Trustees from
October, 1994 until he became Emeritus.

Dr. Vagelos served as Chief Executive Officer of Merck & Co., Inc., for nine years, from July 1985 to June 1994. He was first elected to the Board of Trustees in 1984 and served as its Chairman from April 1986 to November 1994. He was previously Executive Vice President of the worldwide health products company and, before that, President of its Research Division, which he joined in 1975.

Earlier, he served as Chairman of the Department of Biological Chemistry of the School of Medicine at Washington University in St. Louis and as Founding Director of the University's Division of Biology and Biomedical Sciences. He had previously held senior positions in cellular physiology and biochemistry at the National Heart Institute, after internship and residency at Massachusetts General Hospital.

The author of more than 100 scientific papers, Dr. Vagelos received the Enzyme Chemistry Award of the American Chemical Society in 1967. He is a member of the National Academy of Sciences, the American Academy of Arts and Sciences and the American Philosophical Society. He has received honorary Doctor of Science degrees from Washington University, Brown University, the University of Medicine and Dentistry of New Jersey, New York University, Columbia University, the New Jersey Institute of Technology, Mount Sinai Medical Center and the University of British Columbia; an honorary Doctor of Laws degree from Princeton University; and an honorary Doctor of Humane Letters from Rutgers University. He has received the Thomas Alva Edison from Thomas Kean, the Lawrence A. Wein Prize from Columbia University, the C. Walter Nichols Award from New York University's Stern School of Business and the National Academy of Science Award for Chemistry in Service to Society. Dr. Vagelos was awarded the Prince Mahidol Award in January 1998 by His Majesty the King in Bangkok, Thailand.

Dr. Vagelos is a Director of The Prudential Insurance Company of America, PepsiCo, Inc., and The Estee Lauder Companies, Inc. He is Chairman of the Board of Regeneron Pharmaceuticals, Inc. He is Co-Chairman of the New Jersey Performing Arts Center, a Trustee of the Danforth Foundation and Director of the Donald Danforth Plant Science Center.

Book Abstract:
In Medicine, Science, and Merck, the authors trace the careers of a son of Greek immigrants as he mastered three professions and ultimately became the Chief Executive Officer of America’s most admired corporation - the multinational, pharmaceutical giant, Merck & Co., Inc. As the authors show, there was hope even for a wise-cracking kid living through the hard times of the 1930s. Education brought out the scholar in Roy Vagelos, who left his family’s small restaurant to attend the University of Pennsylvania, Columbia’s Medical School, and Massachusetts General Hospital in Boston. At NIH, he mastered biochemistry; at Washington University he became a distinguished science administrator; and at Merck, he headed the pharmaceutical industry’s most innovative laboratory and then became its CEO. Throughout, he never lost touch with his family values, his intense desire to help others, or his faith in the partnership principle and the competition that makes it work.



Home
| About LDI | Contact Us | Senior Fellows | Research | Health Policy | Education | Calendar | Publications | Related Links | Search
Copyright 2004
The Leonard Davis Institute of Health Economics.
All Rights Reserved.